Compare iShares Bitcoin Trust (IBIT) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares Bitcoin Trust vs TransMedics Group Inc — how do they compare? iShares Bitcoin Trust trades at $46.55 (market cap $67.31B), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: iShares Bitcoin Trust is far larger — about 24.6× TransMedics Group Inc's market cap, and iShares Bitcoin Trust is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Bitcoin Trust for 40 Days and TransMedics Group Inc for 24 Days on average.
| IBIT | TMDX | |
|---|---|---|
Market Cap | $67.31B | $2.74B |
Volume | 56,154,544 | 949,331 |
Sector | Crypto-linked | Health |
52-Week High | $68.74 | $150.42 |
52-Week Low | $33.29 | $61.99 |
Typical Hold Time | 40 Days | 24 Days |
Enterprise Value | — | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $46.55, down 1.4% today amid bearish technical signals. The stock faces resistance at $47-$48 with support at $46-$45. Recent news highlights BlackRock's significant inflows into its Bitcoin Trust products, with IBIT attracting $196 million in a single day according to 24/7 Wall Street on October 4, 2026. While technical indicators show mixed signals, institutional interest remains strong despite the current price weakness.
The outlook remains cautious with bearish technical momentum but strong institutional backing. Key risks include ETF flow volatility and broader market sentiment shifts. Upside potential exists if the stock can break above the $48 resistance level, supported by continued institutional investment interest in Bitcoin-related products.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares Bitcoin Trust
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
